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eccentric ventricular mechanical activation. In clinical practice,
overt LV dysfunction is not noted in patients with WPW syn-
drome. The aim of the study was to evaluate the functional con-
sequences of pre-excitation induced mechanical dyssysnchrony
in WPW syndrome.
Methods: Transthoracic echocardiography with TD and Strain
imaging prior to and after (median: 1 day) successful RFA were
analysed in 16 patients with pre-excitation whose electrocardio-
grams were suggestive of a right free wall (RFW-AP; n¼8) or septal
accessory pathway (S-AP; n¼8).
Results: There was no significant depression of LV function in
both groups prior to the procedure with a fractional shortening
(FS) of 35.56 ± 4.24 % and a LVEF of 64.00 ± 1.93 % in the RFWAP
group and a FS of 38.53 ± 2.04 % and LVEF of 62.75 ± 1.67 % in the S-
AP group (p value ¼ 0.141 and 0.147). The difference in the aortic
and pulmonary pre-ejection periods e Inter Venticular Mechani-
cal Delay (IVMD), taken as a measure of interventricular dyssyn-
chrony was 28.63 ± 1.41 ms and 29.25 ± 3.62 ms in right free wall
and septal group. Septal-to-posterior wall motion delay (SPWMD)
as a global measure for LV dyssynchrony showed a decrease in
both groups after successful RFA (61.25 ± 46.43 ms to 26.25 ± 36.62
ms in the right free wall group and 125.00 ± 34.64 ms to 28.75 ±
24.17 ms in the S-AP group. Further analysis with spectral TD, TVI
and longitudinal/radial strain evaluated as the time difference of
QRS onset to peak strain between opposing walls showed no sig-
nificant intraventricular dyssynchrony.
Conclusions: WPW syndromes with RFW or septal APs donot
cause significant inter or intraventricular dyssynchrony and
donot jeopardize global LV function even though SPWMD showed
improvement after RFA in the septal AP group.
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Background: Studies aimed at understanding the demographic,
clinical and interventional therapy indication profiles of Indian
cardiac arrhythmia (CA) and heart failure (HF) patients are scarce.
The purpose of the India PANARrhythMia and Heart Failure Reg-
istry (PANARM HF) was to enroll symptomatic cardiac arrhythmia
and heart failure patients presenting to physicians. Their de-
mographic and cardiovascular profiles were noted. The need for
interventional device/radiofrequency ablation (RFA) therapy as
well as their referral and consultation patterns to interventional
specialists were also recorded.. The results of the registry may
provide information to improve the diagnosis, management and
interventional therapy access of these patients.
Methods: The study included patients seen by non-interven-
tional Consulting Physicians (CP) who medically manage CA and
HF patients and refer them to interventional cardiologists (IC) for
advanced treatment like RF ablation or device implantations. CPs
were trained by ICs to apply a diagnosis protocol (DP) that
recorded details of history, physical exam, ECG and echo to
identify CA/HF patients. 59 CPs evaluated 2205 patients from
over 12 cities across India over a 2 year period. Sixteen ICs ratified
the diagnosis and prescribed appropriate therapy. Registry data
was analyzed to construct detailed demographic, clinical and
device/RFA therapy indication profiles for CA/HF patients pre-
senting to the CP.
Results: The CA/HF distribution of the 2205 patients enrolled were
as follows: HF-58%, bradyarrhythmia-15%, atrial fibrillatione15%,
other supraventricular tachyarrhythmia-10% and ventricular
tachycardia/fibrillatione4.5%. Thirty percent patients presented
with syncope/pre-syncope. The CA/HF population was predomi-
nantly male (62%) and almost 50% were below age 60. Coronary
artery disease (52%), hypertension (44%), diabetes (30%) &
myocardial infarction (20%) were the most prominent clinical
profile of these patients. 64% of the HF patients already had
advanced HF (NYHA III & IV) when they presented to the CP. Sinus
Node Dysfunction (SND) was the most common cause of bra-
dyarrhythmia (55%) compared to 2nd and 3rd degree heart block
(45%).
1011 (46%) of the CA/HF population were potential device/RFA
therapy candidates according to the ICs. 69% of these patients
were referral to the IC. Of the referred patients, only 25% con-
sulted the IC and were recommended therapy. Thus, 83% of pa-
tients in need of interventional therapy did not receive it.
Conclusion: The PANARM HF represents the first detailed de-
mographic and clinical, profiling of CA/HF patients in India. It
provides insight into the referral pattern and penetration of
interventional therapy.
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Background: Catheter ablations are traditionally performed using
fluoroscopic guidance, exposing both patients andmedical staff to
the risks of radiation. The purpose of this study was to evaluate
the feasibility, safety, and efficacy of fluoroless catheter ablation
using 3D Electroanatomical mapping (EAM) in adults being treated
for AVNRT.
Methods: 18 consecutive patients (age 17-67 years) symptomatic
for AVNRT diagnosed on ECG as short RP narrow QRS tachycardia
with typical negative p waves in II,III,aVf and pseudo r in V1,were
prospectively enrolled to right atrium 3D EA mapping and elec-
trophysiological study and radio frequency ablation (RFA) guided
by slow-pathway potential and performed using a 4-mm-tip
catheter.
Results: Sustained slow-fast AVNRT was inducible in all the pa-
tients with a dual AV nodal physiology. Entrainment from RV was
possible in all patients. Post pacing interval and typical VAV
phenomenon confirmed diagnosis of AVNRT and AVRT and AT
were ruled out. Acute success was achieved in 100% of the pa-
tients with a median of four RFA.. Fluoroless ablation was feasible
in all patients using electroanatomical map on En Site system.,
while in two subjects 50 seconds and 45 seconds of x-ray were
needed due to difficult progression of the catheters along the
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venous system. After a mean follow-up of 25 months, AVNRT did
not recur in any patient.
Conclusions: Catheter ablations were efficiently and effectively
performed floroless in adults with AVNRT using 3D Electro-
anatomical mapping using St. Jude En-site system using NavX
patches. This non fluoroscopic technique was feasible, posed no
additional safety concerns, and long term success is documented
on follow up.
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Background: Supraventricular tachycardias cause disabling
symptoms and affect quality of life. Management is pharmaco-
logical and catheter based. Pharmacological treatment is limited
by side effects and less efficacious. Radiofrequency catheter
ablation offers cure for Atrioventricular nodal re-entranrant
tachycardia (AVNRT) with minimal adverse events. Catheter
ablation can be defined as the use of an electrode catheter to
destroy small areas of myocardial tissue or conduction system, or
both, that are critical to the initiation or maintenance of cardiac
arrhythmias. Radio-frequency current is alternating current that
is delivered at cycle lengths of 300 to 750 kHz when used for
catheter ablation. Tissue temperature 50 oC or more causes irre-
versible injury, power- 40- 50 Watts.
Methods: Patients presenting to our centre between 2010-14
diagnosed as AVNRT on EPS were included in this study. Patients
further underwent radiofrequency ablation.
Results: Total number of patients-95.Mean age-38±14yrs.Male/
Female-53/42 .In slow efast pathway type out of 87 patients 80
patients (91%) had successful ablation. In atypical fast-slow path
type out of 5patents 4patiens (80%) had successful ablation. In
sow-intermediate type out of 3 patients 3 (100%) had successful
ablation.
Conclusions: Radiofrequency catheter ablation is safe and effec-
tive treatment for AVNRT. High success rates with low compli-
cation/relapse seen at our center.
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Background: Radiofrequency ablation has emerged as a curative
treatment choice for symptomatic patients with Atrioventricular
Accessory pathways. The aim of the study was to study the effi-
cacy of radiofrequency ablation of symptomatic patients with
accessory pathways and to compare the rates of successful abla-
tion in pathways based on location.
Methods: During the period from july2010 to june2014, 154 pa-
tients with various manifestations of AP underwent EPS and RFA
in NIMS were enrolled and followedup for 6-18 months.
Results: 154 patients with an average age of 22±13 yrs underwent
EPS and RFA. Of these 88 Patients had manifest conduction with a
success rate of 90% and 54 concealed conduction with a success
rate of 89%. No patients had procedural complications.6 patients
had atrial fibrillation with rapid antegrade conduction. 4 patients
had multiple pathways which were successfully ablated. 2 pa-
tients had accessory pathway located at CS diverticulum, 1 patient
underwent successful ablation. 2 patients had recurrence of pre-
excitation (left ant. Lat. and left lat. pathway) and underwent
successful reablation.
Conclusions: Our center reports success rates comparable to
other series reports RFA provides long term durable cure from
disabling symptoms and decrease risk of sudden cardiac death
RFA helps to avoid drug related side effects while providing du-
rable cure for tachycardia and minimizing risk of sudden cardiac
death.
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Background: Dual-chamber pacing (DDD) is believed to have an
advantage over single-chamber ventricular pacing (VVI) with a
higher economic burden and peri-operative complication.
The aim of the study was to determine whether patients with
implanted pacemaker (PM) for complete heart block (CHB) gain
significant immediate and long-term benefit from DDD compared
with VVI Pace maker.
Methods: This prospective experimental study included patients
with CHB and DDD Pacing mode for at least 3 months. Patients
were submitted to a standard protocol, which included clinical
assessment, transthoracic echocardiographic examinations,
quality of life (QoL) questionnaires and 6 minute walk test at base
line and during follow-up. Mode change to VVI for 3 months and
shifting back to DDD was done with follow up at 1st day and 3rd
month in both groups. All these parameters obtained were
compared using t test.
Results: Mean patient age was 55.7 ± 14.7 years and PM
implanted for 23.2 ± 25 months. NYHA FC worsened in VVI group.
PM syndrome was presented in 20% in VVI. The mean walking
distance increased in DDD pacing as compared with VVI pacing
(197 + 100.9 m vs 175 ± 100 m, P ¼ 0.005). Within 24 hours there
was marked decrease in pulmonary artery velocity (80 + 30 vs 102
+ 5.2, P¼ <0.001) and marked reduction in Aortic VTI (20.3 + 4.3 vs
23.4 + 4.8, P¼<0.001) in VVI vs DDD and it continued up to 3
months. Transmitral E velocity in VVI pacing mode showed
higher values (89 +26 VS 68 +20, P¼<0.0001). After 3 months there
was increase in EDV in VVI (104 + 28 vs 103.5 + 27.06, P¼0.042) and
decrement in EF (56.97 +10.42 VS 56.6 +10.6, P¼0.02). There is no
significant enlargement of the left atrium in VVI. QoL was
significantly different between the two groups and was better in
DDD group.
Conclusion: DDD pacemaker is better than VVI pacing in terms of
better Functional class, Qol, lesser incidence of pacemaker syn-
drome and Echocardiographic hemodynamic profile.
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